MHC-I genotype drives early immune selection of oncogenic mutations

MHC-I genotype drives early immune selection of oncogenic mutations

MHC-I exposes the intracellular contents to immune cells for surveillance of cellular health. Due to high genomic variation, individuals' immune systems differ in their ability to expose and eliminate cancer-causing mutations. These personalized immune blind spots create specific oncogenic muta...

Full description

Bibliographic Details
Main Authors:	Rachel Marty, Nicola de Prisco, Hannah Carter, Joan Font-Burgada
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2018-03-01
Series:	Molecular & Cellular Oncology
Subjects:	antigen presentation cancer predisposition cancer susceptibility prediction cancer human leukocyte antigen immunology, immunoediting immunotherapy major histocompatibility complex neoantigens
Online Access:	http://dx.doi.org/10.1080/23723556.2017.1409863

Similar Items

Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy
by: Peng Bai, et al.
Published: (2021-01-01)

Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows
by: Thomas Partridge, et al.
Published: (2018-04-01)

TAPBPR mediates peptide dissociation from MHC class I using a leucine lever
by: F Tudor Ilca, et al.
Published: (2018-11-01)

Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I molecules
by: Georgia F. Papadaki, et al.
Published: (2023-01-01)

Immunogenicity and Immune Silence in Human Cancer
by: Mark Yarmarkovich, et al.
Published: (2020-03-01)

Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
by: Alice Newey, et al.
Published: (2019-11-01)

TSNAD: an integrated software for cancer somatic mutation and tumour-specific neoantigen detection
by: Zhan Zhou, et al.
Published: (2017-01-01)

The MHC locus and genetic susceptibility to autoimmune and infectious diseases
by: Vasiliki Matzaraki, et al.
Published: (2017-04-01)

MergeReference: A Tool for Merging Reference Panels for HLA Imputation
by: Seungho Cook, et al.
Published: (2017-09-01)

Mechanisms of MHC-I Downregulation and Role in Immunotherapy Response
by: Brandie C. Taylor, et al.
Published: (2022-02-01)

Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells
by: Sebastian Montealegre, et al.
Published: (2019-01-01)

HLA-check: evaluating HLA data from SNP information
by: Marc Jeanmougin, et al.
Published: (2017-07-01)

‘Hotspots’ of Antigen Presentation Revealed by Human Leukocyte Antigen Ligandomics for Neoantigen Prioritization
by: Markus Müller, et al.
Published: (2017-10-01)

DeepHLApan: A Deep Learning Approach for Neoantigen Prediction Considering Both HLA-Peptide Binding and Immunogenicity
by: Jingcheng Wu, et al.
Published: (2019-11-01)

Genetic variation in the extended major histocompatibility complex and susceptibility to childhood acute lymphoblastic leukemia: a review of the evidence
by: Kevin Y Urayama, et al.
Published: (2013-12-01)

Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients
by: Francesco Sabbatino, et al.
Published: (2020-10-01)

The biochemistry of antigen presentation
by: Springer, S, et al.
Published: (1996)

IL-6/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 induction
by: Daniel Meraviglia-Crivelli, et al.
Published: (2022-11-01)

The Connection Between Minor H Antigens and Neoantigens and the Missing Link in Their Prediction
by: Tuna Mutis, et al.
Published: (2020-06-01)

MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It
by: Elena Shklovskaya, et al.
Published: (2021-06-01)

Critical Review of Existing MHC I Immunopeptidome Isolation Methods
by: Alexandr Kuznetsov, et al.
Published: (2020-11-01)

MHC Class II Presentation in Autoimmunity
by: Irina A. Ishina, et al.
Published: (2023-01-01)

Frequency of Major Histocompatibility Antigens Class I in Mazandaran Province
by: Fatemeh Toghani Hulari, et al.
Published: (2022-04-01)

ERAP2 Inhibition Induces Cell-Surface Presentation by MOLT-4 Leukemia Cancer Cells of Many Novel and Potentially Antigenic Peptides
by: Ioannis Temponeras, et al.
Published: (2022-02-01)

The Origin and Immune Recognition of Tumor-Specific Antigens
by: Anca Apavaloaei, et al.
Published: (2020-09-01)

Class II Human Leukocyte Antigen (HLA) and Susceptibility to Polypoidal Choroidal Vasculopathy in Afro-Caribbean Descent
by: Merle H, et al.
Published: (2022-04-01)

HLA-alleles class I and II associated with genetic susceptibility to neuromyelitis optica in Brazilian patients
by: Cláudia Suemi Kamoi Kay, et al.
Published: (2019-05-01)

Response to Immune Checkpoint Inhibitors Is Affected by Deregulations in the Antigen Presentation Machinery: A Systematic Review and Meta-Analysis
by: Maria Rasmussen, et al.
Published: (2022-12-01)

Tapasin-mediated editing of the MHC I immunopeptidome is epitope specific and dependent on peptide off-rate, abundance, and level of tapasin expression
by: Denise S. M. Boulanger, et al.
Published: (2022-10-01)

Cancer Vaccines: Antigen Selection Strategy
by: Yue Zhao, et al.
Published: (2021-01-01)

Transethnic analysis of psoriasis susceptibility in South Asians and Europeans enhances fine mapping in the MHC and genome wide
by: Philip E. Stuart, et al.
Published: (2022-01-01)

Epitope Mapping of Pathogenic Autoantigens on Sjögren’s Syndrome-Susceptible Human Leukocyte Antigens Using In Silico Techniques
by: Shivai Gupta, et al.
Published: (2022-03-01)

ROLE OF HLA IN RENAL TRANSPLANT REJECTION
by: A. V. Vatazin, et al.
Published: (2016-02-01)

HISTOCOMPATIBILITY SYSTEM IN RENAL TRANSPLANTATION
by: N. G. Dmitrieva, et al.
Published: (2016-02-01)

A Mechanistic Model for Predicting Cell Surface Presentation of Competing Peptides by MHC Class I Molecules
by: Denise S. M. Boulanger, et al.
Published: (2018-07-01)

Predicting Antigen Presentation—What Could We Learn From a Million Peptides?
by: David Gfeller, et al.
Published: (2018-07-01)

Impact of Antigen Presentation Mechanisms on Immune Response in Autoimmune Hepatitis
by: Rossella Fasano, et al.
Published: (2022-01-01)

Neutrophils in Atlantic salmon (Salmo salar L.) are MHC class II+ and secret IL-12p40 upon bacterial exposure
by: Gyri Teien Haugland, et al.
Published: (2024-03-01)

MHC based suppression (First major revision)
by: Gray, D
Published: (2010)

Exposure of Immunogenic Tumor Antigens in Surrendered Immunity and the Significance of Autologous Tumor Cell-Based Vaccination in Precision Medicine
by: Chiao-Hsu Ke, et al.
Published: (2022-12-01)